Trump says "semaglutide prices will plummet," shares of weight-loss giants Eli Lilly and Novo Nordisk tumble in response.
```
U.S. President Trump stated on Thursday that the price of the popular diabetes drug Ozempic may drop to just $150 per month, causing a stir in the market. This statement led to a sharp decline in the after-hours share prices of Eli Lilly and Novo Nordisk.
On October 16,